Diacylglycerol lipase beta (DAGLβ) activators constitute a unique class of biochemical compounds primarily focused on modulating the activity of the enzyme DAGLβ. This enzyme, a critical component of the endocannabinoid system, plays a vital role in lipid signaling pathways by catalyzing the hydrolysis of diacylglycerol (DAG) to produce 2-arachidonoylglycerol (2-AG), an endogenous ligand for cannabinoid receptors. The activation of DAGLβ by these compounds results in increased production of 2-AG, thereby influencing the dynamics of endocannabinoid signaling. DAGLβ activators are distinguished by their specific interaction with this enzyme, promoting its catalytic efficiency or enhancing its expression, thereby leading to elevated levels of 2-AG in the cellular environment. This class of compounds can vary in structure and origin, encompassing both synthetic molecules and naturally occurring substances that exhibit this specific enzymatic activation property.
The study and development of DAGLβ activators involve intricate biochemical research focusing on the molecular mechanisms governing lipid signaling pathways. These activators are primarily investigated for their role in modulating the biochemical pathways associated with the endocannabinoid system, which is intricately linked to various physiological processes. The interest in DAGLβ activators arises from their unique ability to influence the endocannabinoid system by specifically targeting one of its key enzymatic components. Research in this area delves into understanding the structural and functional aspects of these activators, how they interact with DAGLβ at the molecular level, and the subsequent biochemical consequences of this interaction. Such studies are crucial for comprehending the complex network of lipid signaling and the role of enzymes like DAGLβ in maintaining cellular homeostasis and regulating various physiological functions. The exploration of DAGLβ activators is a vivid example of how specific molecular interactions can have broad implications in the intricate web of cellular signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could upregulate DAGLβ by increasing cAMP levels, potentially enhancing the transcription of genes related to endocannabinoid synthesis. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine might upregulate DAGLβ by demethylating its gene promoter, possibly enhancing transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may increase DAGLβ transcription by altering chromatin structure and accessibility. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG could indirectly upregulate DAGLβ through epigenetic modulation and changes in gene expression patterns. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may upregulate DAGLβ by influencing signaling pathways that regulate gene transcription, including those of endocannabinoid-related enzymes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin might upregulate DAGLβ by modulating transcription factors or epigenetic markers that control its expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane could upregulate DAGLβ through its impact on transcriptional regulation and gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid might potentially upregulate DAGLβ by affecting transcription factors involved in its expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium may influence signaling pathways that affect gene expression, potentially upregulating DAGLβ. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone might modulate lipid metabolism and gene expression, potentially affecting DAGLβ expression. | ||||||